Renalytix Plc reported a net loss of $33.5M in fiscal year 2024. This represents an increase of 26.6% from the prior fiscal year. Over the trailing 12 months, Q2 FY2024 through Q1 FY2025, the same line adds up to a $28.0M net loss. The table below carries 6 fiscal years, from 2019 to 2024, and the quarters Renalytix Plc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RNLXY Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q2 FY2024 through Q1 FY2025, summed from the four most recent quarterly filings.
RNLXY Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Renalytix Plc financials
Frequently Asked Questions
What was Renalytix Plc's net income in fiscal year 2024?
Renalytix Plc reported a net loss of $33.5M in fiscal year 2024.
How fast is Renalytix Plc's net income growing?
Renalytix Plc (RNLXY) net income rose by 26.6% year over year, from -$45.6M to -$33.5M in fiscal year 2024.
What is Renalytix Plc's net income over the last twelve months?
Renalytix Plc (RNLXY) reported a $28.0M net loss over the trailing 12 months, Q2 FY2024 through Q1 FY2025, summed from the four most recent quarterly filings.
How has Renalytix Plc's net income changed over the years?
Across the 6 fiscal years this page covers, Renalytix Plc (RNLXY) net income went from -$42.3M in fiscal year 2019 to -$33.5M in fiscal year 2024.
What was Renalytix Plc's net income in the most recent quarter?
Renalytix Plc (RNLXY) reported -$4.7M in net income in Q1 2025. This represents an increase of 53.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Renalytix Plc (RNLXY) reported on that line in every period on record.